ZADEC ApS

CVR 29312206 · Private limited company (ApS) · Active · Low risk

ZADEC ApS is a Private limited company (ApS), founded on , based in Hørsholm. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 20 annual reports have been published, of which 3 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK -2.7m and a net result of DKK -377k. CEO: Trine Ahlgreen.

Bankruptcy risk for ZADEC ApS

0.5%
probability of bankruptcy within 12 months
Low risk

0.4 × the average (1.41%) · higher risk than 60% of active Danish companies

Lowest riskHighest risk

Increases the risk

Equity ratio< -50% · bankruptcy rate 19.3%2.2×
Negative equityYes · bankruptcy rate 17.5%2.0×
Equity vs. share capital< 0× · bankruptcy rate 17.3%2.0×
Return on assets< -20% · bankruptcy rate 16.7%1.9×
Time since new CEO1 yrs · bankruptcy rate 16.2%1.8×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Loss for the yearYes · bankruptcy rate 10.3%1.2×
Other companies at the same address20–100 · bankruptcy rate 10.2%1.2×

Reduces the risk

Age (years)20+ yrs · bankruptcy rate 2.0%0.23×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×
Share of late annual reports0.01%–25% · bankruptcy rate 4.5%0.51×
Auditor resigned in the last yearYes · bankruptcy rate 4.6%0.52×
Auditor registered in CVRYes · bankruptcy rate 4.8%0.55×
Audit opted outNo · bankruptcy rate 4.8%0.55×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
29312206
Status
Active
Company type
Private limited company (ApS)
Founded
(20 years)
Address
c/o MC2 Therapeutics A/S, Agern Alle 24
2970 Hørsholm
Municipality
Rudersdal
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 500k
Auditor
Cedra Godkendt Revisionsaktieselskab
Audit opted out
No

Warning signs

Annual reports filed late4 of 20
Missing annual reportNo
Negative equityYes
Equity ratio-602.9%
Current ratio14%
Moves (last 2 years)0
CEO changes in total6
CEO's previous bankruptcies0
Other companies at the address74
Going-concern uncertaintyNo

Financials and key figures

Financial year202520242023
Gross profitDKK -116kDKK -85kDKK -150k
Net profitDKK -377kDKK -309kDKK -355k
EquityDKK -2.7mDKK -2.3mDKK -2.0m
Total assetsDKK 449kDKK 437kDKK 434k
CashDKK 443kDKK 431k–
Short-term debtDKK 3.2mDKK 2.8m–
Avg. employees0––

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Deloitte Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 2025183
1 Jan 2024 – 31 Dec 2024181
1 Jan 2023 – 31 Dec 2023186 Late
1 Jan 2022 – 31 Dec 2022188 Late
1 Jan 2021 – 31 Dec 2021181
1 Jan 2020 – 31 Dec 2020182
1 Jan 2019 – 31 Dec 2019225 Late
1 Jan 2018 – 31 Dec 2018157
1 Jan 2017 – 31 Dec 2017162
1 Jan 2016 – 31 Dec 2016109
1 Jan 2015 – 31 Dec 2015155
1 Jan 2014 – 31 Dec 2014139
1 Jan 2013 – 31 Dec 201357
1 Jan 2012 – 31 Dec 2012151
1 Jan 2011 – 31 Dec 2011163
1 Jan 2010 – 31 Dec 2010151
1 Jan 2009 – 31 Dec 2009151
1 Jan 2008 – 31 Dec 2008153
1 Jan 2007 – 31 Dec 2007161
23 Jan 2006 – 31 Dec 2006158

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOTrine AhlgreenCurrent
CEOSteen Sindet-Pedersen
CEOAnette Merete Nøhr Clausen
CEOJesper Jørn Lange
Owner (90%)MC2 Therapeutics A/SCurrent
Owner (5%)FEY HOLDING ApSCurrent
AuditorCedra Godkendt RevisionsaktieselskabCurrent
AuditorDELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB
AuditorDELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
FounderJesper Jørn LangeCurrent

The CEOs' other companies

Trine Ahlgreen – 2 other companies

Steen Sindet-Pedersen – 9 other companies, of which 2 bankrupt

Anette Merete Nøhr Clausen – 16 other companies, of which 1 bankrupt

Jesper Jørn Lange – 13 other companies

Address history (4 moves)

c/o MC2 Therapeutics A/S, Agern Alle 24, 2970 Hørsholm
Agern Alle 24, 2970 Hørsholm
c/o MC2 Biotek ApS, Bøge Alle 5, 2970 Hørsholm
c/o MC2 Biotek ApS, Tuborg Havnevej 19, 2900 Hellerup
c/o Rønne & Lundgren Advokatfirma, Tuborg Havnevej 18, 2900 Hellerup

Other companies at the same address

Similar companies in Rudersdal

Questions and answers about ZADEC ApS

Has ZADEC ApS gone bankrupt?

No, ZADEC ApS is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of ZADEC ApS?

Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.

Who is the CEO of ZADEC ApS?

Trine Ahlgreen is the CEO of ZADEC ApS.

Who is the auditor of ZADEC ApS?

ZADEC ApS most recently used Cedra Godkendt Revisionsaktieselskab.

When was ZADEC ApS founded?

ZADEC ApS was founded on 23 January 2006.

What is the equity of ZADEC ApS?

Equity was DKK -2.7m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.